Information  X 
Enter a valid email address

Genedrive PLC Ord 1.5P (GDR)

Related News

30-May-2022 06:14 PM

IN BRIEF: Genedrive Covid-19 test receives CTDA approval in UK

Genedrive PLC - Manchester-based molecular diagnostics company - Says the UK Medicines & Healthcare Products Regulatory Agency has granted a coronavirus test device approval enabling the sale of the Genedrive COV19-ID Kit in the UK. Genedrive'
29-Mar-2022 11:32 AM

Genedrive soars as UK public health body reviews hearing loss test

Genedrive PLC said on Tuesday that the UK National Institute of Clinical Excellence gave the company's MT-RNR1 hearing loss test a new Medtech Innovation Briefing. Shares in Genedrive were up 18% at 29.50 pence on Tuesday in London.
23-Feb-2022 02:22 PM

IN BRIEF: Genedrive wins distribution agreements for Covid-19 test

Genedrive PLC - Manchester-based molecular diagnostics company - Enters into distribution agreements covering Spain, Portugal, Oman and the United Arab Emirates for its Covid-19 test kit. The company says these initial distributor arrangements are desi
10-Jul-2020 07:39 AM

Genedrive revenue more than halves; regulatory delays weigh on Covid-19 test delivery

Genedrive said revenue more than halved, in line with market expectations, and the medical diagnostics company said delivery of its Covid-19 testing kit was being held back by longer-than-expected regulatory approvals. Revenue for the 12 month period t
04-Feb-2020 09:54 AM

Genedrive cautious on outlook as losses nearly double

Genedrive expressed caution on meeting market forecasts after a 'challenging' first half saw the company's losses nearly double. For the six months to 31 December 2019, pre-tax losses widened to £3.3m, from £1.7m, and revenue
03-Oct-2019 08:36 AM

Genedrive narrows losses on higher revenue despite lower-than-expected Hepatitis C assay sales

Molecular diagnostics company Genedrive reported narrower annual losses as revenue grew by more than fifth even as the company?s sales of its HCV assay fell short of expectations. For the year ended 30 June, pre-tax losses narrowed to £4.5m from &
09-Jul-2019 09:30 AM

Genedrive warns revenue to fall short of expectations amid slower uptake of its HCV ID kit

Genedrive warned it expected revenues to fall short of market expectations as the commercialisation of its HCV ID kit was progressing more slowly than expected. The company said that while it was 'optimistic' about the long-term opportunity t
29-Mar-2019 08:10 AM

Broker Forecast - Peel Hunt issues a broker note on Genedrive Plc

Peel Hunt today reaffirms its buy investment rating on Genedrive Plc (LON:GDR) and set its price target at 60p. Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
15-Jan-2019 02:18 PM

Genedrive sees first-half revenue rising 15% after US defense contract win

Molecular diagnostics company Genedrive said it posted a rise in first-half revenue, largely owing to it winning a new contract with the US defense department. Revenue for the six months through December rose 15% to £1.5m and largely comprised the
13-Jul-2018 09:05 AM

Genedrive performance meets expectations despite annual revenue slump

Molecular diagnostics group Genedrive said Friday revenue was in line with expectations despite falling 26.7% for the year through June. For the twelve months ended 30 June 2018, revenue fell 26.9% to £1.9m from £2.6m the previous year. Th
04-Apr-2018 11:30 AM

Broker Forecast - Peel Hunt issues a broker note on Genedrive Plc

Peel Hunt today reaffirms its buy investment rating on Genedrive Plc (LON:GDR) and set its price target at 152p. Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
27-Feb-2018 11:10 AM

Broker Forecast - Peel Hunt issues a broker note on Genedrive Plc

Peel Hunt today reaffirms its buy investment rating on Genedrive Plc (LON:GDR) and raised its price target to 152p (from 150p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
17-Jan-2018 07:52 AM

genedrive diagnostic revenues rise

genedrive said group revenue for the six months to the end of December was was £2.6m (2016: £2.8m) with with diagnostic (Genedrive) related revenue of £1.3m (2016: £1.2m). It said diagnostic revenue was largely comprised of the
16-Jan-2018 07:55 AM

genedrive reveals positive results from field study

genedrive has announced successful results of the first field study of its Genedrive hetaptitis C (HCV) ID kit in Africa. genedrive said the study was performed in Johannesburg at Lancet Laboratories, one of the leading private pathology testing labora
29-Nov-2017 02:21 PM

All resolutions passed at AGM of Genedrive

Genedrive has confirmed that all resolutions were passed by shareholders at today's Annual General Meeting. At 2:21pm: (LON:GDR) Genedrive Plc share price was 0p at 36p Story provided by StockMarketWire.com...
21-Nov-2017 09:13 AM

genedrive awarded £600,000 Innovate UK grant

genedrive, the near patient molecular diagnostics company, has been formally awarded an Innovate UK grant for the development of a disposable centrifuge-free plasma separation consumable device. In its preliminary results issued in October, genedrive co
17-Nov-2017 02:10 PM

Genedrive schedules AGM

Genedrive has confirmed that the Company intends to hold its Annual General Meeting on 29 November. At 2:10pm: (LON:GDR) Genedrive Plc share price was 0p at 37.5p Story provided by StockMarketWire.com...
08-Nov-2017 02:10 PM

Genedrive CEO steps down

Genedrive has announced that Chief Operating Officer, Allan Brown, will leave the Company as part of a planned change to the management team structure. The Company added that he will step down from the Board with immediate effect but will continue to be
02-Nov-2017 08:09 AM

genedrive terminates distribution agreement with Xcelris

genedrive has terminated its distribution arrangements in India/SAARC with Xcelris. genedrive said that as previously announced, commercialisation of the MTB/RIF tuberculosis tests in India has been challenging for some time. genedrive said that init
25-Oct-2017 08:00 AM

Broker Forecast - Peel Hunt issues a broker note on Genedrive Plc

Peel Hunt today initiates coverage of Genedrive Plc (LON:GDR) with a buy investment rating and price target of 150p. Story provided by StockMarketWire.com...
17-Oct-2017 07:30 AM

genedrive trading losses narrow

Trading losses at genedrive - the near patient molecular diagnostics company - narrowed to £4.9m in the year to the end of June from £5.4m last time, despite increased research & development and administrative costs. Turnover rose by 13.7% to
16-Oct-2017 07:22 AM

genedrive inks distribution deal with Sysmex Europe

genedrive has signed a distribution agreement with Sysmex Europe for the Genedrive HCV ID Kit and Genedrive platform in the EMEA region with an initial focus on Africa. genedrive and Sysmex Europe anticipate commercialisation beginning in the coming mon
13-Jul-2017 09:38 AM

genedrive revenues rise

genedrive said it continued the good progress made in its first half and full year revenues for the 12 months to the end of June rose to £5.8m (2016: £5.1m). It said diagnostic (Genedrive) related revenue totalled £2.6m (2016: £1
11-Apr-2017 07:57 AM

Genedrive to present hepatitis C data at EASL

Genedrive has confirmed that hepatitis C assay performance data had been accepted for presentation at the International Liver Confrence. The company said it would be showcasing its molecular Genedrive HCV ID Kit and Genedrive platform at the conference
30-Mar-2017 09:53 AM

Genedrive operating losses narrow

Genedrive's operating losses fell to £2.4m in the six months to the end of December - down from £3.1m last time. Revenues and other income rose to £2.9m from £1.97m. Chief executive David Budd said: The recent period has see

a d v e r t i s e m e n t